The same-sounding pain tablet can differ in salt form, strength, approval documents, safety profile and commercial terms. By the end, you will be able to compare the formulation with competing combinations, assess Haryana districts, verify a supplier’s paperwork and judge whether exclusivity and reorder economics are worth accepting.
Key takeaways
- Check the prescription, NSAID risks and paracetamol limits before comparing brands.
- Ask for a Form 20B licence copy and product batch documents.
- Compare district exclusivity, minimum orders, expiry policy and payment terms.
- Choose the supplier with verified quality records and clear written commitments.
How does diclofenac-serratiopeptidase compare with competing pain combinations?
The 50 mg diclofenac potassium plus 325 mg paracetamol plus 15 mg serratiopeptidase tablet is not automatically the best choice for every pain, injury or swelling complaint. Diclofenac supplies the principal NSAID analgesic and anti-inflammatory action; paracetamol adds analgesic and antipyretic activity.
| Option | Main distinction | Prescriber trade-off |
|---|---|---|
| Diclofenac potassium 50 mg + paracetamol 325 mg + serratiopeptidase 15 mg | Adds a proteolytic enzyme to diclofenac and paracetamol | Serratiopeptidase supports an enzyme-related swelling or tissue-recovery position, but its routine added clinical benefit is less firmly established |
| Diclofenac + paracetamol | Uses the same principal NSAID and analgesic-antipyretic pairing without the enzyme | Simpler positioning, with no serratiopeptidase-related claim to substantiate |
| Diclofenac + paracetamol + chlorzoxazone | Adds a centrally acting muscle relaxant | More relevant where muscle spasm is part of the presentation; it is not a general substitute for an enzyme combination |
| Aceclofenac + paracetamol + serratiopeptidase | Replaces diclofenac with aceclofenac, another NSAID | The NSAID choice, tolerability, approved indication and label wording change; do not treat it as the same product |
Serratiopeptidase does not replace diclofenac, and claims that it “removes swelling” or makes diclofenac safer require support from the approved label. Count paracetamol from cold, fever and other pain medicines to avoid duplication.
For pcd pharma franchise diclofenac serratiopeptidase in haryana, compare the exact salt, strength, dosage form, pack size and approved label. Do not select on brand name or tablet price alone. The label must support the promotional claim.
What prescription and safety checks must accompany the product comparison?
1. State that diclofenac tablets are Schedule H medicines in India. A diclofenac paracetamol tablet pcd listing must not present them as unrestricted over-the-counter products; promotional material must direct selection and use to a clinician.
2. Require a prescription-level safety screen before promotion. Flag duplicate NSAIDs, including ibuprofen, naproxen, aspirin and another diclofenac product. Identify gastrointestinal ulcer or bleeding, kidney disease, liver disease, uncontrolled hypertension and cardiovascular disease as reasons for clinician review. Pregnancy-related restrictions also require clinician assessment.
3. Keep the dosing message within safe boundaries: commonly cited adult maximum systemic diclofenac exposure is 150 mg per day, using the lowest effective dose for the shortest duration. Show the product’s paracetamol content as 325 mg per tablet and instruct reviewers to count paracetamol in every medicine, including cold and fever products.
4. Confirm the exact fixed-dose combination before comparing or advertising it. Individual approval of diclofenac, paracetamol or serratiopeptidase does not automatically approve every combination, strength or dosage form; request the specific manufacturing permission or loan-licence documentation.
5. Complete the supplier file with Schedule M GMP evidence, approved label and pack-artwork review, batch certificate and batch-level traceability. Match the promotional claim to the approved label, because claims such as “removes swelling” cannot substitute for authorised product information.
How should you compare Haryana districts and franchise arrangements?
A diclofenac serratiopeptidase tablet franchise in Haryana depends on demand for the enzyme combination; a diclofenac-paracetamol tablet PCD arrangement may reach more general-medicine prescribers but faces heavier direct brand competition. Do not compare them by strip margin alone.
| Arrangement | Demand pattern | Main comparison |
|---|---|---|
| Diclofenac plus serratiopeptidase | Orthopaedic, dental and post-operative positioning | Enzyme-related demand must be proven locally |
| Diclofenac plus paracetamol | Broad general-practice and pain demand | Wider use, more competing brands |
| Either arrangement | Prescription-led distribution | Match stock to prescriber reach and reorder timing |
Build one scorecard for each district and nearby market:
- Ambala, Panchkula, Yamunanagar, Kurukshetra, Karnal, Rohtak, Hisar and Gurugram: record orthopaedic, dental, general-practice and surgical prescribers, including their patient reach.
- Record hospital and clinic density, medical-store coverage, competing brands, field-staff travel time and expected reorder interval.
- Mark Gurugram and Panchkula as urban, hospital-led territories; assess Hisar and Kurukshetra for mixed town-and-rural coverage rather than copying that model.
Define the offer as district monopoly, town exclusivity or non-exclusive supply. A monopoly clause must name the geography, product list, duration, minimum purchase, default conditions, stock-return terms and recall procedure. It cannot block regulatory withdrawal or another legally authorised supply channel.
The phrase pharma franchise products in Ambala describes a sales territory, not a special approval category. Verify the distributor’s licence, storage, invoices, transport controls and product permissions.
Which documents and commercial terms should a Haryana distributor demand?
Before paying or accepting a territory, a pcd pharma distributor in haryana should obtain a written file and commercial schedule. Ask for:
- Composition and specification sheet, including salt, strength, dosage form and pack size
- Approved label, pack artwork, manufacturing licence details and applicable Form 20-B or Form 21-B wholesale documentation
- Fixed-dose combination permission or loan-licence papers
- Current GMP information under Schedule M, batch certificate of analysis and storage conditions
- GST invoice format, price list, minimum order quantity and promotional-material list
| Term to confirm | Supplier must state | Why it matters |
|---|---|---|
| Dispatch | Expiry remaining at dispatch and batch-release timing | Short dating creates dead stock |
| Fulfilment | Delivery time and freight responsibility | Delays disrupt pharmacy supply |
| Payment | Credit period and payment triggers | Prevents unexpected cash exposure |
| Exceptions | Damage replacement, near-expiry policy, complaint escalation and recall process | Defines your remedy |
Compare opening stock depth with forecast reorder frequency. A low minimum order is not attractive if replenishment takes weeks or batches arrive close to expiry.
Require invoices showing product name, batch number, expiry, quantity and seller details; preserve them for traceability. Treat “removes swelling” or “safer than diclofenac” as warning signs until the approved label and supporting evidence justify the claim. Get every monopoly, return and replacement promise in writing.
How can you choose between suppliers after the paperwork is verified?
Score suppliers with weights instead of choosing the highest strip margin. Record every answer in one spreadsheet and ask Varmed Pharma Pvt Ltd and every competing manufacturer or PCD supplier the same questions; the company name alone proves neither quality, exclusivity nor compliance.
| Criterion | What to verify | Suggested weight |
|---|---|---|
| Product permission and batch documents | Combination licence or loan-licence papers, approved label and batch certificate of analysis | 20% |
| Stock and expiry | Repeated availability and expiry remaining at dispatch | 15% |
| Delivery performance | Promised versus actual delivery time | 10% |
| Territory protection | Written, enforceable boundary, product list, duration and default terms | 15% |
| Promotion and medical-representative support | Materials, prescriber visits and reporting | 10% |
| Replacement policy | Damage, shortage, complaint and recall handling | 10% |
| Reorder simplicity | Clear process, realistic minimum order and invoice trail | 10% |
| Commercial fit | Minimum purchases matched to the district’s prescriber base | 10% |
Check whether the territory is a district, town or named account; a verbal monopoly promise has no dependable boundary. Test the repeat-order process with a small, documented opening order only after licence and product checks are complete.
Reject any proposal that:
- Hides the batch certificate or refuses to state expiry policy.
- Sets purchases beyond realistic local demand.
- Encourages unrestricted consumer advertising for a Schedule H medicine.
- Offers exclusivity without written geography, duration, minimum purchase, stock-return and default terms.
Choose the supplier that balances clinical positioning, traceability and sustainable stock movement, not the largest printed discount.
Related product
 | TABLET Diclofenace Potassium 50 mg+ Paracetamol 325 mg+Serratiopeptidase 15 mg ₹1000 Voldo-SP Tablet combines Diclofenac, Paracetamol & Serratiopeptidase to deliver powerful relief from pain, swelling, and inflammation associated with... View product → |
Frequently asked questions
How does diclofenac-serratiopeptidase compare with competing pain combinations?
Compare the active ingredients, strengths, dosage form, intended use, contraindications and total paracetamol exposure. A 50 mg diclofenac potassium plus 325 mg paracetamol plus 15 mg serratiopeptidase tablet is not automatically suitable for every pain or swelling complaint.
What prescription and safety checks should accompany the comparison?
Check the prescription, allergy history, stomach ulcer or bleeding risk, kidney and liver disease, cardiovascular risk, pregnancy status and other NSAID or paracetamol use. Do not combine it with another diclofenac product or exceed the prescribed paracetamol limit.
How should you compare Haryana districts and franchise arrangements?
Compare territory population, doctor and pharmacy coverage, competing distributors, travel time, stockist access and written district exclusivity. Confirm whether the arrangement covers one district, selected towns or the entire state.
Which documents and commercial terms should a Haryana distributor demand?
Request the supplier's GST details, drug licence copies, product composition and approved label, batch test or quality documents, price list, invoice terms, minimum order, expiry replacement policy, transport responsibility and written authorization for the territory.
How can you choose between suppliers after the paperwork is verified?
Score suppliers on documented quality, supply reliability, landed cost, expiry protection, territory clarity, credit terms, customer support and complaint handling. Select the offer with the clearest written obligations rather than the lowest quoted price.
